Gilead Sciences Inc (NASDAQ:GILD)

68.65
Delayed Data
As of Jan 17
 +1.01 / +1.49%
Today’s Change
60.32
Today|||52-Week Range
89.54
+9.75%
Year-to-Date

Today’s Trading

Previous close67.64
Today’s open67.54
Day’s range67.46 - 68.96
Volume5,224,528
Average volume (3 months)7,447,030
Market cap$86.3B
Data as of 4:15pm ET, 01/17/2019

Growth & Valuation

Earnings growth (last year)-64.88%
Earnings growth (this year)-21.97%
Earnings growth (next 5 years)-2.77%
Revenue growth (last year)-13.79%
P/E ratio56.3
Price/Sales3.62
Price/Book4.27

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+6.31+1.90%
AMGNAmgen+3.03+1.52%
ILMNIllumina Inc+4.42+1.45%
TLRYTilray Inc-2.16-2.52%
Data as of 4:15pm ET, 01/17/2019

Financials

Next reporting dateFebruary 4, 2019
EPS forecast (this quarter)$1.71
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Patient Officer
Gregg H. Alton
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts